VRTX : Summary for Vertex Pharmaceuticals Incorpor - Yahoo Finance

U.S. Markets closed

Vertex Pharmaceuticals Incorporated (VRTX)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
80.91-1.61 (-1.95%)
At close: 4:00PM EST
People also watch
ALXNREGNBMRNBIIBINCY
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close82.52
Open82.55
Bid80.00 x 100
Ask87.64 x 100
Day's Range80.51 - 82.67
52 Week Range71.46 - 103.73
Volume1,525,135
Avg. Volume2,095,993
Market Cap20.07B
Beta1.80
PE Ratio (TTM)-71.35
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • American City Business Journals7 minutes ago

    Seaport traffic gets dose of relief as Vertex joins shuttle program

    Vertex Pharmaceuticals began using the Seaport District bus shuttles managed by the Massachusetts Convention Center Authority this month, boosting a service whose future was in doubt as recently as last year. When the MCCA launched the service in 2015, its goal was to consolidate the shuttles that Seaport businesses use to ferry their employees to and from MBTA commuter-rail stations. Through last spring, however, the service was dropping off and picking up riders at just one Seaport location: PricewaterhouseCoopers’ office at 101 Seaport Blvd. Other businesses in the traffic-clogged neighborhood had declined to come on board, unable to agree on how to split funding or how often shuttles should run.

  • 24/7 Wall St.14 hours ago

    Baird Has 4 Red-Hot Biotechs to Buy for 2017 With Huge Upside Potential

    A recent research report from the biotech team at Baird offers their top picks for 2017. While hardly pounding the table, they are cautiously optimistic on the industry.

  • Vertex Pharma (VRTX) Q4 Earnings: Stock Likely to Beat?
    Zacks14 hours ago

    Vertex Pharma (VRTX) Q4 Earnings: Stock Likely to Beat?

    We expect biotech company Vertex Pharmaceuticals, Inc. (VRTX) to beat expectations when it reports fourth-quarter 2016 and full-year earnings results on Jan 25, after the market closes.